全文获取类型
收费全文 | 21661篇 |
免费 | 1423篇 |
国内免费 | 167篇 |
专业分类
耳鼻咽喉 | 359篇 |
儿科学 | 386篇 |
妇产科学 | 413篇 |
基础医学 | 2882篇 |
口腔科学 | 521篇 |
临床医学 | 1963篇 |
内科学 | 4505篇 |
皮肤病学 | 634篇 |
神经病学 | 1367篇 |
特种医学 | 1221篇 |
外科学 | 2793篇 |
综合类 | 780篇 |
现状与发展 | 1篇 |
一般理论 | 14篇 |
预防医学 | 1106篇 |
眼科学 | 732篇 |
药学 | 1679篇 |
中国医学 | 170篇 |
肿瘤学 | 1725篇 |
出版年
2023年 | 204篇 |
2022年 | 434篇 |
2021年 | 775篇 |
2020年 | 444篇 |
2019年 | 550篇 |
2018年 | 708篇 |
2017年 | 511篇 |
2016年 | 622篇 |
2015年 | 824篇 |
2014年 | 1009篇 |
2013年 | 1089篇 |
2012年 | 1715篇 |
2011年 | 1662篇 |
2010年 | 946篇 |
2009年 | 850篇 |
2008年 | 1178篇 |
2007年 | 1161篇 |
2006年 | 1128篇 |
2005年 | 1067篇 |
2004年 | 847篇 |
2003年 | 697篇 |
2002年 | 568篇 |
2001年 | 536篇 |
2000年 | 517篇 |
1999年 | 417篇 |
1998年 | 157篇 |
1997年 | 139篇 |
1996年 | 112篇 |
1995年 | 113篇 |
1994年 | 110篇 |
1993年 | 78篇 |
1992年 | 163篇 |
1991年 | 186篇 |
1990年 | 147篇 |
1989年 | 158篇 |
1988年 | 144篇 |
1987年 | 160篇 |
1986年 | 126篇 |
1985年 | 117篇 |
1984年 | 86篇 |
1983年 | 73篇 |
1982年 | 47篇 |
1980年 | 44篇 |
1979年 | 68篇 |
1978年 | 41篇 |
1977年 | 46篇 |
1975年 | 46篇 |
1974年 | 45篇 |
1972年 | 41篇 |
1969年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
Margaret Seto-Poon Melanie Madronio Jason P Kirkness Terence C Amis Karen Byth Chong Lee Lim 《Clinical neurophysiology》2005,116(5):1172-1180
OBJECTIVE: To examine response decrement of the recently reported inspiratory skin conductance response (SCR) [Lim CL, Seto-Poon M, Clouston PD, Morris JG. Sudomotor nerve conduction velocity and central processing time of the skin conductance response. Clin Neurophysiol 2003;114:2172-80]. METHODS: Twelve healthy adult volunteers performed 3 tasks (A) a control task of maintaining tidal breathing and then two randomized tasks, (B) a deep inspiration to a target oral pressure and (C) tapping with a finger. Each task was performed 30 times on cue every 20s in 3 runs with 5 min of rest between runs. The SCR, oral pressure, airflow, inspired volume and cue signal were recorded continuously and analysed offline. SCR amplitude was logarithmically transformed and then statistically analysed, using a linear mixed effects model, as a function of run number, trial number and absolute error between target and actual oral pressures. RESULTS: Inspiratory efforts elicited exponentially decreasing SCR amplitude with increasing trial number during each run (P < 0.0001). After adjusting for trial number, the mean SCR amplitude of the second and the third run were, respectively, 24.2 (95% CI (0.175, 0.336), P < 0.001) and 14.4% (95% CI (0.104, 0.200), P < 0.001) of the first run amplitude. CONCLUSIONS: Volitional deep inspiration reliably activates an SCR that exhibits response decrement with repetition, which may be habituation. SIGNIFICANCE: The volitional inspiratory SCR may assist in the assessment of sympathetic autonomic status in patients with peripheral afferent neuropathy. 相似文献
42.
43.
Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics? A systematic review. 总被引:1,自引:0,他引:1
E J Waterman L A Magee K I Lim A Skoll D Rurak P von Dadelszen 《Hypertension in pregnancy》2004,23(2):155-169
OBJECTIVE: To examine fetal (FHR) and neonatal heart rate patterns following use of common oral antihypertensives in pregnancy. METHODS: A systematic review of randomized controlled trials (RCTs), observational studies (N >/= 6 women), and animal studies. Data were abstracted (two reviewers) to determine relative risk (RR) (or risk difference (RD) for low event rates) and 95% CI. RESULTS: Eighteen RCTs (1858 women), one controlled observational study (N = 22), and seven case series (N = 117) were reviewed. Most hypertension was pregnancy-induced (N = 14 studies). The FHR was assessed by cardiotocogram (CTG) (N = 17 studies (visual interpretation); 1 study (computerized CTG), or umbilical artery velocimetry (N = 4). Four studies examined neonatal heart rate. In placebo-controlled RCTs (N = 192 women), adverse FHR effects did not differ between groups [9/101 (drugs) vs. 7/91 (placebo); RD 0.02, 95% CI (- 0.06, 0.11); chi2 = 1.02]. In six drug vs. drug RCTs (295 women), adverse FHR effects did not differ between groups [29/144 (methyldopa) vs. 42/151 (other drugs); RR 0.72, 95% CI (0.49, 1.07); chi2 = 0.69]. In one labetalol vs. placebo trial, neonatal bradycardia did not differ between groups [4/70 (labetalol) vs. 4/74 (placebo); OR 1.06, 95% CI (0.26, 4.39)], while in three drug vs. drug RCTs, neonatal bradycardia was not observed (0/24 vs. 0/26). CONCLUSIONS: Available data are inadequate to conclude whether oral methyldopa, labetalol, nifedipine, or hydralazine adversely affect fetal or neonatal heart rate and pattern. Until definitive data are available, FHR changes cannot be reliably attributed to drug effect, but may be due to progression of the underlying maternal or placental disease. 相似文献
44.
45.
46.
We have reported a case of idiopathic hypereosinophilic syndrome (HES) with polymyositis, in which there was marked eosinophilic leukocytic infiltration of the myocardium and striated skeletal muscles, particularly of the diaphragm, with foci of necrosis and areas of fibrosis. We believe this to be the first detailed report of the involvement of the diaphragm in HES. 相似文献
47.
D Komiotis C T Lim J P Dieter G C Le Breton D L Venton 《Journal of medicinal chemistry》1992,35(16):3033-3039
Previous observations implicating PgH2 as a direct activator of platelets suggested that derivatives of U46619, a well-characterized TxA2 receptor agonist having structural homology with PgH2, might possess antiplatelet activity. The present work describes the synthesis of [1S-(1 alpha,2 beta,3 alpha,4 alpha)]-3-[(tetrahydropyranyloxy)methyl]- 2-[2-[(triphenylmethyl)oxy]ethyl]-5-oxabicyclo[2.2.1]heptane (14) a potentially useful intermediate for the synthesis of various epoxymethano derivatives. The latter was converted to [1S-(1 alpha,2 beta (Z),3 alpha,4 alpha)]-7-[3-[[2- [(phenylamino)carbonyl]-hydrazino]methyl]-5-oxabicylo[2.2.1]hept-2 - yl]-5-heptenoic acid (23), an epoxymethano derivative of PgH2 containing a hydrazide lower side chain as previously used in the TxA2 antagonist, SQ 29,548. The intermediate 14 was also converted to [1S-(1 alpha,2 beta (Z),3 alpha,4 alpha)]-7- [3-[(hexylamino)methyl]-5-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (25) which contained a simple aza side chain as used in earlier antagonists. Derivatives 23 and 25 appeared to be specific antagonists of the human platelet TxA2 receptor as evidenced by their inhibition of U46619 (1.5 microM) induced aggregation of human platelet rich plasma (IC50 = 22 and 7 microM, respectively), while having little effect on ADP (2 microM) induced aggregation at much higher concentrations. In addition, one of these derivatives, the bicycloamine 25, was shown to compete for [3H]U46619 binding to washed human platelets with an IC50 value of 25 microM, supporting the notion that these derivatives were acting at the thromboxane receptor. However, the potency of these derivatives was less than for previously reported TxA2 antagonists, suggesting that simple linear combinations of functionality from molecules active at the human platelet thromboxane receptor will be of limited predictive value. 相似文献
48.
49.
50.
Brigitte Schiller Chun He David J. Salant Alice Lim Jessy J. Alexander Richard J. Quigg 《The Journal of experimental medicine》1998,188(7):1353-1358
Crry (complement receptor 1–related protein/gene y) is a key cellular complement regulator in rodents. It is also present in Fx1A, the renal tubular preparation used to immunize rats to induce active Heymann nephritis (HN), a model of membranous nephropathy. We hypothesized that rats immunized with anti-Fx1A develop autoantibodies (auto-Abs) to Crry as well as to the megalin-containing HN antigenic complex, and that anti-Crry Abs promote the development of injury in HN by neutralizing the complement regulatory activity of Crry. Rats immunized with Fx1A lacking Crry remained free of proteinuria and glomerular deposits of C3 during a 10-wk follow-up despite typical granular immunoglobulin (Ig)G deposits in glomeruli. Anti-Fx1A auto-Abs were present in their sera at levels that were not different from sera pooled from proteinuric rats with HN induced with nephritogenic Fx1A. Passive administration of sheep anti-Crry Abs to rats immunized with Crry-deficient Fx1A led to proteinuria and glomerular C3 deposition, which were not seen in such rats injected with preimmune IgG, nor in rats with collagen-induced arthritis injected with anti-Crry IgG. To directly examine the role of Crry in HN, rats were immunized with Crry-deficient Fx1A reconstituted with rCrry. This led to typical HN, with 8 out of 15 rats developing proteinuria within 14 wk. Moreover, the extent of glomerular C3 deposition correlated with proteinuria, and anti-Crry Abs were present in glomerular eluates. Thus, Crry is a key nephritogenic immunogen in Fx1A. Formation of neutralizing auto-Abs to Crry impairs its function, leading to unrestricted complement activation by Abs reactive with the HN antigenic complex on the epithelial cell surface. 相似文献